- ►endojournals.org R Muniyappa, M Montagnani, KK Koh, MJ … - Endocrine reviews, 2007 - Endocrine Soc Insulin has important vascular actions to stimulate production of nitric oxide
from endothelium. This leads to capillary recruitment, vasodilation, increased
blood flow, and subsequent augmentation of glucose disposal in classical ... Cited by 99 - Related articles - BL Direct - All 5 versions
- ►nih.gov M Chakir, GE Plante - Prostaglandins, Leukotrienes & Essential Fatty Acids, 1996 - Elsevier In the present study, we examined the pattern of Evan's blue (EB) extravasation
over time and we verified the effect of two inhibitors of aldose reductase
(sorbinil and ARI 509) as well as aminoguanidine, which modulate nitric ... Cited by 34 - Related articles - BL Direct - All 12 versions
- ►nursing2008.com E Mannucci, M Monami, C Lamanna, GF … - Diabetes, Obesity and Metabolism, 2008 - pt.wkhealth.com Aim: The aim of this meta-analysis of randomized clinical trials (RCT) was to
assess whether pioglitazone is also associated with increased cardiovascular
risk, as recently reported for rosiglitazone. Methods: RCT of pioglitazone ... Cited by 14 - Related articles - All 6 versions
DA Lawlor, A Fraser, S Ebrahim, GD Smith - PLoS Med, 2007 - medicine.plosjournals.org We undertook a prospective cohort study of 3,246 British women aged 60–79 y,
all of whom were free of baseline coronary heart disease, stroke, and diabetes,
and all of whom had fasting glucose levels below 7 mmol/l. Fasting insulin ... Cited by 16 - Related articles - Cached - All 9 versions
BJ Goldstein - International journal of clinical practice, 2006 - interscience.wiley.com Recent clinical research has provided a wealth of information to support optimal
management strategies in type 2 diabetes mellitus (T2DM). In particular, outcome
studies appropriately have had an increasingly important impact on clinical ... Cited by 13 - Related articles - BL Direct - All 5 versions
T Forst, E Karagiannis, G Lübben, C Hohberg, … - Atherosclerosis, 2008 - Elsevier During Pioglitazone treatment, a 12% reduction in MMP-9 and a 18% reduction in
hsCRP levels (p < 0.05, respectively) could be observed already after 3 days.
MCP-1 levels were reduced by 14% after 10 days of treatment (p < 0.0001). ... Cited by 10 - Related articles - All 28 versions
C Lockhart, P Hamilton, K Mcveigh, G … - Diabetes Obesity and Metabolism, 2008 - pt.wkhealth.com Diabetes mellitus is a potent risk factor for the development of a wide spectrum
of cardiovascular (CV) complications. The complex metabolic milieu accompanying
diabetes alters blood rheology, the structure of arteries and disrupts the ... Cited by 8 - Related articles - BL Direct - All 6 versions
H Sasaki, K Ogawa, M Shimizu, C Mori, H … - International heart journal, 2007 - J-STAGE S UMMARY We investigated the effects of ischemic preconditioning (IP) on
reperfusion arrhyth- mias in type 2 diabetic rats as well as the effects of the
insulin sensitizer pioglitazone. Thirty-week-old OLETF rats with or without ... Cited by 6 - Related articles - BL Direct - All 5 versions
A Ceriello, TUK Ltd - Diabetes/Metabolism Reviews - interscience.wiley.com In the last few years, there has been increasing focus on the impact of
interventions on cardiovascular outcomes in patients with type 2 diabetes.
Insulin resistance and hyperglycaemia often co-exist with a cluster of risk ... Cited by 7 - Related articles - BL Direct - All 3 versions
T Matsumoto, T Kobayashi, K Kamata - Journal of Smooth Muscle Research, 2008 - J-STAGE Macro- and microvascular disorders currently represent the principal causes of
morbidity and mortality in patients with diseases involving the cardiovascular
system, such as atherosclerosis, hypertension, stroke, and diabetes. ... Cited by 6 - Related articles - All 2 versions
